Stem Cell Application Group (2020) Chinese consensus of allogeneic hematopoietic stem cell transplantation for hematological disease (III) -acute graft-versus-host disease. Zhonghua Xue Ye Xue Za Zhi 41:529–536
Kanda Y, Kobayashi T, Mori T, Tanaka M, Nakaseko C et al (2016) A randomized controlled trial of cyclosporine and tacrolimus with strict control of blood concentrations after unrelated bone marrow transplantation. Bone Marrow Transplant 51:103–109
Article PubMed CAS Google Scholar
Robinson DH, Hughes CFM, Grigg A (2020) Optimal oral cyclosporin dosing with concomitant posaconazole post allogeneic stem cell transplantation. Leuk Lymphoma 61:2448–2452
Article PubMed CAS Google Scholar
Wang YN, Li MX, Xi R, Li N, Cai YG (2019) Retrospective analysis of monitoring results of plasma cyclosporine A concentration in patients with allogeneic hematopoietic stem cell transplantation. J Logist Univ PAP 28:1–7
Tian J, Zhang P, Wang X, Liao Y, Li S, Yan H (2018) Analysis of blood concentration of cyclosporine A in patients after hematopoietic stem cell transplantation. China Mod Med 25:11–16
Penack O, Marchetti M, Ruutu T, Aljurf M, Bacigalupo A, Bonifazi F et al (2020) Prophylaxis and management of graft versus host disease after stem-cell transplantation for haematological malignancies: updated consensus recommendations of the European Society for Blood and Marrow Transplantation. Lancet Haematol 7:e157–e167
Barnoud D, Pincon C, Bruno B, Béné J, Gautier S, Lahoche A et al (2018) Acute kidney injury after high dose etoposide phosphate: a retrospective study in children receiving an allogeneic hematopoetic stem cell transplantation. Pediatr Blood Cancer 65:e27038
Koh KN, Sunkara A, Kang G, Sooter A, Mulrooney DA, Triplett B et al (2018) Acute kidney injury in pediatric patients receiving allogeneic hematopoietic cell transplantation: incidence, risk factors, and outcomes. Biol Blood Marrow Transplant 24:758–764
Kurokawa M, Nishiyama K, Koga Y, Eguchi K, Imai T, Oba U et al (2020) Hyperferritinemia and acute kidney injury in pediatric patients receiving allogeneic hematopoietic cell transplantation. Pediatr Nephrol 35:1977–1984
Matsuoka D, Hirabayashi K, Murase T, Saito S, Nakazawa Y (2021) Impact of acute kidney injury on overall survival in children and young adults undergoing allogeneic hematopoietic stem cell transplantation. Pediatr Blood Cancer 68:e29167
Article PubMed CAS Google Scholar
Bao YS, Xie RJ, Wang W, Jiang EL, Huang Y, Wei JL et al (2010) Clinical analysis of acute kidney injury in patients with acute leukemia following myeloablative allogenetic hematopoietic cell transplantation. Chin J Organ Transplant 31:618–620
Kist-van Holthe JE, Goedvolk CA, Brand R, Vanweel MH, Bredius RG, Van Oostayen JA et al (2002) Prospective study of renal insufficiency after bone marrow transplantation. Pediatr Nephrol 17:1032–1037
Saddadi F, Najafi I, Hakemi M, Falaknazi K, Attari F, Bahar B (2010) Frequency, risk factors, and outcome of acute kidney injury following bone marrow transplantation at Dr Shariati Hospital in Tehran. Iran J Kidney Dis 4:20–26
Xu J, Jin R (2023) Research progress in complications related to hematopoietic stem cell transplantation in children with aplastic anemia. J Clin Pediatr 41:175–180
Menezes M, Marques A, Chuva T, Vaz C, Ferreira H, Branca R et al (2022) Acute kidney injury after allogeneic hematopoietic stem cell transplantation - predictors and survival impact: a single center retrospective study. Nefrologia (Engl Ed) 42:656–663
Koh K, Park M, Kim B, Bae K, Im H, Seo J (2011) Favorable outcomes after allogeneic hematopoietic stem cell transplantation in children with high-risk or advanced acute myeloid leukemia. J Pediatr Hematol Oncol 33:281–288
Shaw P, Kan F, Ahn K, Spellman S, Aljurf M, Ayas M et al (2010) Outcomes of pediatric bone marrow transplantation for leukemia and myelodysplasia using matched sibling, mismatched related, or matched unrelated donors. Blood 116:4007–4015
留言 (0)